
Chembio Diagnostics (NASDAQ:CEMI) brought in sales totaling $20.57 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 119.5%, resulting in a loss of $13.97 million. Chembio Diagnostics collected $12.06 million in revenue during Q3, but reported earnings showed a $6.37 million loss.